Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
51
OGI.TO Quote, Financials, Valuation and Earnings
Last price:
$2.41
Seasonality move
:
19.81%
Day range:
$2.36 - $2.42
52-week range:
$1.22 - $3.09
Dividend yield:
0%
P/E ratio:
129.47x
P/S ratio:
1.20x
P/B ratio:
0.93x
Volume:
141.5K
Avg. volume:
416.9K
1-year change:
7.11%
Market cap:
$324.1M
Revenue:
$259.2M
EPS (TTM):
-$0.21
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OGI.TO
Organigram Global, Inc.
|
$75.8M | -$0.01 | 71.72% | -80% | $3.40 |
|
ACB.TO
Aurora Cannabis, Inc.
|
$99M | -$0.03 | 4.79% | -91.67% | $7.80 |
|
CRON.TO
Cronos Group, Inc.
|
$65.5M | -$0.07 | 33.92% | -156.68% | $3.95 |
|
TSND.TO
Terrascend Corp.
|
$91.2M | -$0.03 | -12.43% | -74.49% | $1.74 |
|
WEED.TO
Canopy Growth Corp.
|
$71.8M | $0.06 | -5.09% | -95.48% | $3.76 |
|
XLY.TO
Auxly Cannabis Group, Inc.
|
$35.9M | -- | 18.12% | -- | $0.2500 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OGI.TO
Organigram Global, Inc.
|
$2.41 | $3.40 | $324.1M | 129.47x | $0.00 | 0% | 1.20x |
|
ACB.TO
Aurora Cannabis, Inc.
|
$6.27 | $7.80 | $354.7M | 116.20x | $0.00 | 0% | 0.96x |
|
CRON.TO
Cronos Group, Inc.
|
$3.76 | $3.95 | $1.4B | 28.61x | $0.00 | 0% | 7.82x |
|
TSND.TO
Terrascend Corp.
|
$1.10 | $1.74 | $336M | -- | $0.00 | 0% | 0.85x |
|
WEED.TO
Canopy Growth Corp.
|
$1.78 | $3.76 | $609.1M | -- | $0.00 | 0% | 1.16x |
|
XLY.TO
Auxly Cannabis Group, Inc.
|
$0.1450 | $0.2500 | $195.5M | 4.75x | $0.00 | 0% | 1.45x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OGI.TO
Organigram Global, Inc.
|
2.45% | 2.654 | 2.31% | 1.21x |
|
ACB.TO
Aurora Cannabis, Inc.
|
15.87% | 1.055 | 19.86% | 1.52x |
|
CRON.TO
Cronos Group, Inc.
|
0.16% | 1.773 | 0.16% | 20.73x |
|
TSND.TO
Terrascend Corp.
|
73.06% | 5.012 | 98.87% | 0.71x |
|
WEED.TO
Canopy Growth Corp.
|
26.05% | 4.059 | 38.43% | 4.06x |
|
XLY.TO
Auxly Cannabis Group, Inc.
|
27.67% | -1.082 | 33.75% | 1.03x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OGI.TO
Organigram Global, Inc.
|
$416K | -$28M | -6.89% | -7.06% | -35.03% | -$554K |
|
ACB.TO
Aurora Cannabis, Inc.
|
-$8M | -$56M | -9.13% | -10.69% | -61.96% | -$46.7M |
|
CRON.TO
Cronos Group, Inc.
|
$24.8M | -$6.9M | 3.71% | 3.71% | -13.83% | $12.4M |
|
TSND.TO
Terrascend Corp.
|
$44.7M | $15.3M | -14.74% | -38.6% | 17.11% | $620.3K |
|
WEED.TO
Canopy Growth Corp.
|
$16.9M | -$16.4M | -39.84% | -68.7% | -24.59% | -$19.4M |
|
XLY.TO
Auxly Cannabis Group, Inc.
|
$8.8M | -$4.1M | 22.71% | 34.07% | -10.27% | $8.3M |
Organigram Global, Inc. vs. Competitors
-
Which has Higher Returns OGI.TO or ACB.TO?
Aurora Cannabis, Inc. has a net margin of -47.42% compared to Organigram Global, Inc.'s net margin of -58.83%. Organigram Global, Inc.'s return on equity of -7.06% beat Aurora Cannabis, Inc.'s return on equity of -10.69%.
Company Gross Margin Earnings Per Share Invested Capital OGI.TOOrganigram Global, Inc.0.52% -$0.28 $357.9M ACB.TOAurora Cannabis, Inc.-8.86% -$0.91 $667.4M -
What do Analysts Say About OGI.TO or ACB.TO?
Organigram Global, Inc. has a consensus price target of $3.40, signalling upside risk potential of 41.08%. On the other hand Aurora Cannabis, Inc. has an analysts' consensus of $7.80 which suggests that it could grow by 24.4%. Given that Organigram Global, Inc. has higher upside potential than Aurora Cannabis, Inc., analysts believe Organigram Global, Inc. is more attractive than Aurora Cannabis, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OGI.TOOrganigram Global, Inc.3 1 0 ACB.TOAurora Cannabis, Inc.2 2 0 -
Is OGI.TO or ACB.TO More Risky?
Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Aurora Cannabis, Inc. has a beta of 1.098, suggesting its more volatile than the S&P 500 by 9.781%.
-
Which is a Better Dividend Stock OGI.TO or ACB.TO?
Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aurora Cannabis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Aurora Cannabis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OGI.TO or ACB.TO?
Organigram Global, Inc. quarterly revenues are $80.1M, which are smaller than Aurora Cannabis, Inc. quarterly revenues of $90.4M. Organigram Global, Inc.'s net income of -$38M is higher than Aurora Cannabis, Inc.'s net income of -$53.2M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 129.47x while Aurora Cannabis, Inc.'s PE ratio is 116.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.20x versus 0.96x for Aurora Cannabis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OGI.TOOrganigram Global, Inc.1.20x 129.47x $80.1M -$38M ACB.TOAurora Cannabis, Inc.0.96x 116.20x $90.4M -$53.2M
-
Which has Higher Returns OGI.TO or CRON.TO?
Cronos Group, Inc. has a net margin of -47.42% compared to Organigram Global, Inc.'s net margin of 77.94%. Organigram Global, Inc.'s return on equity of -7.06% beat Cronos Group, Inc.'s return on equity of 3.71%.
Company Gross Margin Earnings Per Share Invested Capital OGI.TOOrganigram Global, Inc.0.52% -$0.28 $357.9M CRON.TOCronos Group, Inc.49.47% $0.09 $1.6B -
What do Analysts Say About OGI.TO or CRON.TO?
Organigram Global, Inc. has a consensus price target of $3.40, signalling upside risk potential of 41.08%. On the other hand Cronos Group, Inc. has an analysts' consensus of $3.95 which suggests that it could grow by 5.05%. Given that Organigram Global, Inc. has higher upside potential than Cronos Group, Inc., analysts believe Organigram Global, Inc. is more attractive than Cronos Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OGI.TOOrganigram Global, Inc.3 1 0 CRON.TOCronos Group, Inc.1 1 0 -
Is OGI.TO or CRON.TO More Risky?
Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Cronos Group, Inc. has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.958%.
-
Which is a Better Dividend Stock OGI.TO or CRON.TO?
Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cronos Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Cronos Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OGI.TO or CRON.TO?
Organigram Global, Inc. quarterly revenues are $80.1M, which are larger than Cronos Group, Inc. quarterly revenues of $50.1M. Organigram Global, Inc.'s net income of -$38M is lower than Cronos Group, Inc.'s net income of $39M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 129.47x while Cronos Group, Inc.'s PE ratio is 28.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.20x versus 7.82x for Cronos Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OGI.TOOrganigram Global, Inc.1.20x 129.47x $80.1M -$38M CRON.TOCronos Group, Inc.7.82x 28.61x $50.1M $39M
-
Which has Higher Returns OGI.TO or TSND.TO?
Terrascend Corp. has a net margin of -47.42% compared to Organigram Global, Inc.'s net margin of -15.22%. Organigram Global, Inc.'s return on equity of -7.06% beat Terrascend Corp.'s return on equity of -38.6%.
Company Gross Margin Earnings Per Share Invested Capital OGI.TOOrganigram Global, Inc.0.52% -$0.28 $357.9M TSND.TOTerrascend Corp.49.87% -$0.12 $487.1M -
What do Analysts Say About OGI.TO or TSND.TO?
Organigram Global, Inc. has a consensus price target of $3.40, signalling upside risk potential of 41.08%. On the other hand Terrascend Corp. has an analysts' consensus of $1.74 which suggests that it could grow by 57.99%. Given that Terrascend Corp. has higher upside potential than Organigram Global, Inc., analysts believe Terrascend Corp. is more attractive than Organigram Global, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OGI.TOOrganigram Global, Inc.3 1 0 TSND.TOTerrascend Corp.4 0 0 -
Is OGI.TO or TSND.TO More Risky?
Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Terrascend Corp. has a beta of 1.913, suggesting its more volatile than the S&P 500 by 91.314%.
-
Which is a Better Dividend Stock OGI.TO or TSND.TO?
Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Terrascend Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Terrascend Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OGI.TO or TSND.TO?
Organigram Global, Inc. quarterly revenues are $80.1M, which are smaller than Terrascend Corp. quarterly revenues of $89.7M. Organigram Global, Inc.'s net income of -$38M is lower than Terrascend Corp.'s net income of -$13.6M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 129.47x while Terrascend Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.20x versus 0.85x for Terrascend Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OGI.TOOrganigram Global, Inc.1.20x 129.47x $80.1M -$38M TSND.TOTerrascend Corp.0.85x -- $89.7M -$13.6M
-
Which has Higher Returns OGI.TO or WEED.TO?
Canopy Growth Corp. has a net margin of -47.42% compared to Organigram Global, Inc.'s net margin of -2.46%. Organigram Global, Inc.'s return on equity of -7.06% beat Canopy Growth Corp.'s return on equity of -68.7%.
Company Gross Margin Earnings Per Share Invested Capital OGI.TOOrganigram Global, Inc.0.52% -$0.28 $357.9M WEED.TOCanopy Growth Corp.25.3% -$0.01 $995.3M -
What do Analysts Say About OGI.TO or WEED.TO?
Organigram Global, Inc. has a consensus price target of $3.40, signalling upside risk potential of 41.08%. On the other hand Canopy Growth Corp. has an analysts' consensus of $3.76 which suggests that it could grow by 111.24%. Given that Canopy Growth Corp. has higher upside potential than Organigram Global, Inc., analysts believe Canopy Growth Corp. is more attractive than Organigram Global, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OGI.TOOrganigram Global, Inc.3 1 0 WEED.TOCanopy Growth Corp.1 4 1 -
Is OGI.TO or WEED.TO More Risky?
Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Canopy Growth Corp. has a beta of 1.930, suggesting its more volatile than the S&P 500 by 92.97%.
-
Which is a Better Dividend Stock OGI.TO or WEED.TO?
Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Canopy Growth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Canopy Growth Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OGI.TO or WEED.TO?
Organigram Global, Inc. quarterly revenues are $80.1M, which are larger than Canopy Growth Corp. quarterly revenues of $66.7M. Organigram Global, Inc.'s net income of -$38M is lower than Canopy Growth Corp.'s net income of -$1.6M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 129.47x while Canopy Growth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.20x versus 1.16x for Canopy Growth Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OGI.TOOrganigram Global, Inc.1.20x 129.47x $80.1M -$38M WEED.TOCanopy Growth Corp.1.16x -- $66.7M -$1.6M
-
Which has Higher Returns OGI.TO or XLY.TO?
Auxly Cannabis Group, Inc. has a net margin of -47.42% compared to Organigram Global, Inc.'s net margin of 51.36%. Organigram Global, Inc.'s return on equity of -7.06% beat Auxly Cannabis Group, Inc.'s return on equity of 34.07%.
Company Gross Margin Earnings Per Share Invested Capital OGI.TOOrganigram Global, Inc.0.52% -$0.28 $357.9M XLY.TOAuxly Cannabis Group, Inc.22.15% $0.01 $238.5M -
What do Analysts Say About OGI.TO or XLY.TO?
Organigram Global, Inc. has a consensus price target of $3.40, signalling upside risk potential of 41.08%. On the other hand Auxly Cannabis Group, Inc. has an analysts' consensus of $0.2500 which suggests that it could grow by 72.41%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Organigram Global, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Organigram Global, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OGI.TOOrganigram Global, Inc.3 1 0 XLY.TOAuxly Cannabis Group, Inc.1 0 0 -
Is OGI.TO or XLY.TO More Risky?
Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Auxly Cannabis Group, Inc. has a beta of 1.254, suggesting its more volatile than the S&P 500 by 25.413%.
-
Which is a Better Dividend Stock OGI.TO or XLY.TO?
Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Auxly Cannabis Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Auxly Cannabis Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OGI.TO or XLY.TO?
Organigram Global, Inc. quarterly revenues are $80.1M, which are larger than Auxly Cannabis Group, Inc. quarterly revenues of $39.9M. Organigram Global, Inc.'s net income of -$38M is lower than Auxly Cannabis Group, Inc.'s net income of $20.5M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 129.47x while Auxly Cannabis Group, Inc.'s PE ratio is 4.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.20x versus 1.45x for Auxly Cannabis Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OGI.TOOrganigram Global, Inc.1.20x 129.47x $80.1M -$38M XLY.TOAuxly Cannabis Group, Inc.1.45x 4.75x $39.9M $20.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
